[1]
|
Guyatt G, Cairns J, Churchill D, et al. Evidence-based Medicine: A New Approach to Teaching the Practice of Medicine[J]. JAMA, 1992, 268: 2420-2425. doi: 10.1001/jama.1992.03490170092032 |
[2]
|
Djulbegovic B, Guyatt GH. Progress in evidence-based medicine: a quarter century on[J]. Lancet, 2017, 390: 415-423. doi: 10.1016/S0140-6736(16)31592-6 |
[3]
|
Sackett DL, Straus SE, Scott Richardson W, et al. Evidence-Based Medicine: How to Practice and Teach EBM[M]. 2nd ed. Edinburgh and London: Churchill Livingstone, 2000. |
[4]
|
杨克虎. 循证医学[M]. 北京: 人民卫生出版社, 2019: 7-8. |
[5]
|
Wang J. Evidence-based medicine in China[J]. Lancet, 2010, 37: 532-523. |
[6]
|
Li B, Yan Y, Lv M, et al. Clinical Epidemiology in China series. Paper 1: Evidence-based medicine in China: An oral history study[J]. J Clin Epidemiol, 2021, 140: 165-171. doi: 10.1016/j.jclinepi.2021.08.012 |
[7]
|
Richardson WS, Wilson MC, Nishikawa J, et al. The well-built clinical question: a key to evidence-based decisions[J]. ACP J Club, 1995, 123: A12-A13. |
[8]
|
孙皓, 时景璞. 循证医学中PICO模型的扩展及其在定性研究中的应用[J]. 中国循证医学杂志, 2014, 1: 505-508. doi: 10.7507/1672-2531.20140087 |
[9]
|
朱政, 胡雁, 邢唯杰, 等. 不同类型循证问题的构成[J]. 护士进修杂志, 2017, 32: 1991-1994. doi: 10.16821/j.cnki.hsjx.2017.21.025 |
[10]
|
Cooke A, Smith D, Booth A. Beyond PICO: the SPIDER tool for qualitative evidence synthesis[J]. Qual Health Res, 2012, 22: 1435-1443. doi: 10.1177/1049732312452938 |
[11]
|
Robinson KA, Saldanha IJ, McKoy NA. Development of a framework to identify research gaps from systematic reviews[J]. J Clin Epidemiol, 2011, 64: 1325-1330. doi: 10.1016/j.jclinepi.2011.06.009 |
[12]
|
Chalmers I, Hedges LV, Cooper H. A brief history of research synthesis[J]. Eval Health Prof, 2002, 25: 12-37. doi: 10.1177/0163278702025001003 |
[13]
|
Guyatt G. Guides to the Medical Literature: A Manual for Evidence-Based Clinical Practice[M]. 3rd ed. McGraw Hill/Medical, 2014: 675. |
[14]
|
李幼平, 李静, 孙鑫, 等. 循证医学在中国的起源与发展: 献给中国循证医学20周年[J]. 中国循证医学杂志, 2016, 16: 2-6. doi: 10.7507/1672-2531.20160002 |
[15]
|
Cochrane. Homepage[EB/OL]. [2022-11-30]. https://www.cochrane.org/. |
[16]
|
Institute of Medicine (US) Committee on Standards for Developing Trustworthy Clinical Practice Guidelines. Clinical Practice Guidelines We Can Trust[M]. Washington (DC): National Academies Press, 2011. |
[17]
|
The Cochrane Community. Review production, Production resources, Living systematic reviews[EB/OL]. (2019-12)[2022-11-27]. https://community.cochrane.org/review-production/production-resources/living-systematic-reviews. |
[18]
|
Norris SL. Current definitions of living systematic reviews and living guidelines need to change[J]. J Evid Based Med, 2022, 15: 75-76. doi: 10.1111/jebm.12478 |
[19]
|
许吉, 邓宏勇. 动态系统评价简介[J]. 中国循证医学杂志, 2020, 20: 244-248. https://www.cnki.com.cn/Article/CJFDTOTAL-ZZXZ202002018.htm |
[20]
|
Dobbins M. Rapid review guidebook[J]. Natl Collab Cent Method Tools, 2017, 13: 25. |
[21]
|
University Libraries. Libraries, Research Guides, Health Science Libraries, Systematic Reviews & Other Review Types, What is a Rapid Review?[EB/OL]. (2020-10-15)[2022-11-27]. https://guides.temple.edu/c.php?g=78618&p=4156608. |
[22]
|
Pollock M, Fernandes RM, Becker LA, et al. Chapter V: Overviews of Reviews. In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (editors). Cochrane Handbook for Systematic Reviews of Interventions version 6.3[EB/OL]. (2022-02)[2022-11-30]. https://training.cochrane.org/handbook/current/chapter-v. |
[23]
|
杨克虎, 刘雅莉, 袁金秋, 等. 发展和完善中的系统评价再评价[J]. 中国循证儿科杂志, 2011, 6: 54-57. doi: 10.3969/j.issn.1673-5501.2011.01.009 |
[24]
|
Belbasis L, Bellou V, Ioannidis JPA. Conducting umbrella reviews[J]. BMJ Medicine, 2022, 1: e000071. doi: 10.1136/bmjmed-2021-000071 |
[25]
|
Bougioukas KI, Pamporis K, Vounzoulaki E, et al. Types and associated methodologies of overviews of reviews in healthcare: a methodological study with published examples[J]. J Clin Epidemiol, 2022, 153: 13-25. |
[26]
|
孙鑫, 王莉, 李幼平. 使用个体病例数据进行Meta分析评价医疗干预措施的效果[J]. 中国循证医学杂志, 2010, 10: 998-1003. https://www.cnki.com.cn/Article/CJFDTOTAL-ZZXZ201008022.htm |
[27]
|
李伦, 杨克虎, 田金徽. 网状Meta分析相关术语和定义的研究[J]. 中国药物评价, 2014, 31: 321-326. doi: 10.3969/j.issn.2095-3593.2014.06.001 |
[28]
|
Higgins JP, Welton NJ. Network meta-analysis: a norm for comparative effectiveness?[J]. Lancet, 2015, 386: 628-630. doi: 10.1016/S0140-6736(15)61478-7 |
[29]
|
Colquhoun HL, Levac D, O'Brien KK, et al. Scoping reviews: time for clarity in definition, methods, and reporting[J]. J Clin Epidemiol, 2014, 67: 1291-1294. doi: 10.1016/j.jclinepi.2014.03.013 |
[30]
|
卞薇, 陈慧, 宋国敏, 等. 概况性评价简介[J]. 中国循证医学杂志, 2017, 17: 488-493. doi: 10.7507/1672-2531.201608004 |
[31]
|
Miake-Lye IM, Hempel S, Shanman R, et al. What is an evidence map? A systematic review of published evidence maps and their definitions, methods, and products[J]. Syst Rev, 2016, 5: 28. doi: 10.1186/s13643-016-0204-x |
[32]
|
李伦, 杨克虎, 田金徽, 等. 一种新的证据总结方法: 证据图简介[J]. 中国循证儿科杂志, 2011, 6: 230-232. https://www.cnki.com.cn/Article/CJFDTOTAL-XZEK201103023.htm |
[33]
|
Tran L, Tam DNH, Elshafay A, et al. Quality assessment tools used in systematic reviews of in vitro studies: A systematic review[J]. BMC Med Res Methodol, 2021, 21: 101. |
[34]
|
Seehra J, Pandis N, Koletsi D, et al. Use of quality assessment tools in systematic reviews was varied and inconsistent[J]. J Clin Epidemiol, 2016, 69: 179-184.e5. doi: 10.1016/j.jclinepi.2015.06.023 |
[35]
|
Jørgensen L, Paludan-Müller AS, Laursen DR, et al. Evaluation of the Cochrane tool for assessing risk of bias in randomized clinical trials: overview of published comments and analysis of user practice in Cochrane and non-Cochrane reviews[J]. Syst Rev, 2016, 5: 80. doi: 10.1186/s13643-016-0259-8 |
[36]
|
Guyatt GH, Rennie D. Users'guides to the medical literature[J]. JAMA, 1993, 270: 2096-2097. |
[37]
|
The periodic health examination. Canadian Task Force on the Periodic Health Examination[J]. Can Med Assoc J, 1979, 121: 1193-1254. |
[38]
|
SUNY Downstate Medical Research Library of Brooklyn: Evidence-Based Medicine Course. Evidence Based Pyramid[EB/OL]. (2022-07-18)[2022-11-05]. https://guides.downstate.edu/c.php?g=856794&p=6831536. |
[39]
|
SING50: a guideline developer's handbook[EB/OL]. (2019-11)[2022-11-05]. https://www.sign.ac.uk/our-guidelines/sign-50-a-guideline-developers-handbook/. |
[40]
|
Jeremy Howick, Iain Chalmers, Paul Glasziou, et al. "Explanation of the 2011 Oxford Centre for Evidence-Based Medicine (OCEBM) Levels of Evidence (Background Document)". Oxford Centre for Evidence-Based Medicine[EB/OL]. [2022-11-05]. https://www.cebm.ox.ac.uk/resources/levels-of-evidence/explanation-of-the-2011-ocebm-levels-of-evidence. |
[41]
|
Atkins D, Eccles M, Flottorp S, et al. Systems for grading the quality of evidence and the strength of recommendations I: critical appraisal of existing approaches The GRADE Working Group[J]. BMC Health Serv Res, 2004, 4: 38. |
[42]
|
陈耀龙, 李幼平, 杜亮, 等. 医学研究中证据分级和推荐强度的演进[J]. 中国循证医学杂志, 2008, 8: 127-133. https://www.cnki.com.cn/Article/CJFDTOTAL-ZZXZ200802015.htm |
[43]
|
Enhancing the QUAlity and Transparency Of health Research. What is a reporting guideline?[EB/OL]. [2022-11-25]. https://www.equator-network.org/about-us/what-is-a-reporting-guideline/. |
[44]
|
Begg C, Cho M, Eastwood S, et al. Improving the quality of reporting of randomizedcontrolled trials. The CONSORT statement[J]. JAMA, 1996, 276: 637-639. |
[45]
|
Moher D, Schulz KF, Altman DG, et al. The CONSORT statement: revised recommendations for improv-ing the quality of reports of parallel-group randomized trials[J]. Ann Intern Med, 2001, 134: 657-662. |
[46]
|
Schulz KF, Altman DG, Moher D, et al. CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials[J]. BMJ, 2010, 340: c332. |
[47]
|
Campbell MK, Piaggio G, Elbourne DR, et al. Consort 2010 statement: extension to cluster randomised trials[J]. BMJ, 2012, 345: e5661. |
[48]
|
Boutron I, Altman DG, Moher D, et al. CONSORT Statement for Randomized Trials of Nonpharmacologic Treatments: A 2017 Update and a CONSORT Extension for Nonpharmacologic Trial Abstracts[J]. Ann Intern Med, 2017, 167: 40-47. |
[49]
|
MacPherson H, Altman DG, Hammerschlag R, et al. Revised STandards for Reporting Interventions in Clinical Trials of Acupuncture (STRICTA): extending the CON-SORT statement[J]. PLoS Med, 2010, 7: e1000261. |
[50]
|
Dwan K, Li T, Altman DG, et al. CONSORT 2010 statement: extension to randomised crossover trials[J]. BMJ, 2019, 366: l4378. |
[51]
|
CONSORT. About CONSORT, History[EB/OL]. (1996-08-28)[2022-11-30]. http://www.consort-statement.org/. |
[52]
|
R. Brian Haynes, 陈耀龙, 刁骧. 研究、综述、摘要、总结、系统: 循证卫生保健决策的"5S"信息服务演进[J]. 中国循证医学杂志, 2007, 7: 330-332. https://www.cnki.com.cn/Article/CJFDTOTAL-ZZXZ200705001.htm |
[53]
|
DiCenso A, Bayley L, Haynes RB. ACP Journal Club. Editorial: Accessing preappraised evidence: fine-tuning the 5S model into a 6S model[J]. Ann Intern Med, 2009, 151: JC3-2, JC3-3. |
[54]
|
McMaster University Health Sciences Library. Resources for Evidence-based Practice: The 6S Pyramid[EB/OL]. (2022-11-10)[2022-11-27]. https://hslmcmaster.libguides.com/ebm. |
[55]
|
杨楠, 赵巍, 潘旸, 等. 针对临床实践指南科学性、透明性和适用性的评级工具研发[J]. 中华医学杂志, 2022, 102: 2329-2337. |
[56]
|
中华医学会杂志社指南与标准研究中心, 中国医学科学院循证评价与指南研究创新单元, 世界卫生组织指南实施与知识转化合作中心. 2021年医学期刊发表中国指南和共识的科学性、透明性和适用性的评级[J]. 中华医学杂志, 2022, 102: 2319-2328. |
[57]
|
孙鑫, 李玲, 李舍予, 等. 促进高质量临床实践指南快速制订与有效使用: MAGIC体系与中国行动[J]. 中国循证医学杂志, 2020, 20: 2-6. https://www.cnki.com.cn/Article/CJFDTOTAL-ZZXZ202001002.htm |
[58]
|
Schünemann HJ, Reinap M, Piggott T, et al. The ecosystem of health decision making: from fragmentation to synergy[J]. Lancet Public Health, 2022, 7: e378-e390. |
[59]
|
杨克虎. 循证社会科学的产生、发展与未来[J]. 图书与情报, 2018(03): 1-10. https://www.cnki.com.cn/Article/CJFDTOTAL-BOOK201803001.htm |
[60]
|
裴淼, 靳伟, 李肖艳, 等. 循证教师教育实践: 内涵、价值和运行机制[J]. 教师教育研究, 2020, 32: 1-8. https://www.cnki.com.cn/Article/CJFDTOTAL-GDSZ202004001.htm |